Alzamend Neuro Soars on Breakthrough Trial News: Is This Biotech Stock a Hidden Gem?

Alright, folks, buckle up because we’re diving into the wild world of biotech stocks, and today,…

Amgen's SWOT analysis: biotech giant's stock faces obesity market challenge

Amgen's SWOT analysis: biotech giant's stock faces obesity market challenge#Amgen039s #SWOT #analysis #biotech #giant039s #stock #faces…

Protagenic Therapeutics Skyrockets on Merger with Phytanix Bio: A Biotech Powerhouse in the Making?

Holy cow, folks, the market’s on fire today, and Protagenic Therapeutics (Nasdaq: PTIX) is leading the…

FBT: This 30-Stock Biotech ETF Isn't Worth The Risk Today

FBT: This 30-Stock Biotech ETF Isn't Worth The Risk Today #FBT #30Stock #Biotech #ETF #Isn039t #Worth…

Oncolytics Biotech Inc. (ONCY) Q1 2025 Earnings Call Transcript

Oncolytics Biotech Inc. (ONCY) Q1 2025 Earnings Call Transcript #Oncolytics #Biotech #ONCY #Earnings #Call #Transcript

Legend Biotech Corporation 2025 Q1 – Results – Earnings Call Presentation

Legend Biotech Corporation 2025 Q1 – Results – Earnings Call Presentation #Legend #Biotech #Corporation #Results #Earnings…

Sarepta, other biotech stocks tumble as FDA appoints new CBER director

Sarepta, other biotech stocks tumble as FDA appoints new CBER director#Sarepta #biotech #stocks #tumble #FDA #appoints…

Arvinas: Yet Another Biotech Trading Below Net Cash, But It's Only A Mild Bull Case

Arvinas: Yet Another Biotech Trading Below Net Cash, But It's Only A Mild Bull Case #Arvinas…

Kiniksa Pharmaceuticals: A Biotech Stock on the Rise, But What’s Next?

As of this writing, Kiniksa Pharmaceuticals International Plc (KNSA) has seen a significant price movement in…

IO Biotech Showcases Scientific Leadership Through Cancer Vaccines Educational Session at the American Association for Cancer Research (AACR) Annual Meeting 2025

IO Biotech Showcases Scientific Leadership Through Cancer Vaccines Educational Session at the American Association for Cancer…

Regeneron: Still A Biotech Juggernaut

Regeneron: Still A Biotech Juggernaut #Regeneron #Biotech #Juggernaut

The AI Revolution in Biotech: Recursion Pharmaceuticals Soars 19.18% on FDA’s New Approach to Animal Testing

In a move that has sent shockwaves through the biotechnology sector, the U.S. Food and Drug…

Oncolytics Biotech ® Funds Pelareorep's Ongoing Clinical Development with a Share Purchase Agreement in Partnership with Alumni Capital

Oncolytics Biotech ® Funds Pelareorep's Ongoing Clinical Development with a Share Purchase Agreement in Partnership with…

Keros Therapeutics: A Biotech Stock on the Move Amid Strategic Review and Rights Plan

In a move that’s got investors buzzing, Keros Therapeutics (NASDAQ: KROS) has announced a review of…

PacBio’s Revival: A Closer Look at the Biotech Stock on a Roll

In today’s fast-paced market, it’s not uncommon for stocks to experience sudden surges in value. But…

Solid Biosciences: A Strong Buy As An Emerging Biotech In The Gene Therapy Space

Solid Biosciences: A Strong Buy As An Emerging Biotech In The Gene Therapy Space #Solid #Biosciences…

Absci Corporation: A Potential Turnaround Play In Biotech Amid A Tumultuous Market

Absci Corporation: A Potential Turnaround Play In Biotech Amid A Tumultuous Market #Absci #Corporation #Potential #Turnaround…

Biotech Stocks Q1 2025 Recap: Winners And Underperformers

This article was written by Follow Edmund Ingham is a biotech consultant. He has been covering…

CorMedix Stock: A Fair-Priced Biotech Company With A Bright Future (NASDAQ:CRMD)

This article was written by Follow I am a dynamic finance professional with a Master’s in…

Oncolytics Biotech: Continuing To Justify The Negativity

Oncolytics Biotech: Continuing To Justify The Negativity #Oncolytics #Biotech #Continuing #Justify #Negativity

Gains on equity deals and biotech breakthroughs

and RYSE Hey 360 – here are some of our top movers today! ? Special Invite Only…

TG Therapeutics: A Biotech Stock on the Rise, But What’s Behind Its Recent Surge?

In a market where biotechnology stocks are often shrouded in uncertainty, TG Therapeutics (NASDAQ:TGTX) has emerged…